# Kiora Pharmaceuticals Inc: Form 8-K, filed Jan 31, 2024

- Company: [Kiora Pharmaceuticals Inc](/companies/kprx.md) (CIK 1372514)
- Form: 8-K
- Filed: 2024-01-31
- Accepted by EDGAR: Jan 31, 2024, 17:14 ET
- Period: 2024-01-25
- Accession: 0001372514-24-000007
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1372514/000137251424000007/kprx-20240125.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1372514/000137251424000007/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1372514/000137251424000007/kprx-20240125.htm

Filed Jan 31, 2024.
Source: SEC EDGAR, the filing index for accession 0001372514-24-000007. Last ingested by Listed: Nov 12, 2026, 17:43 ET. No prices; not investment advice.